Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Stock
Equities
2315
CNE100005D27
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.89 CNY | +1.95% | -7.01% | -25.79% |
May. 06 | Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies | CI |
Apr. 26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
Sales 2024 * | 919M 127M | Sales 2025 * | 1.15B 158M | Capitalization | 3.29B 454M |
---|---|---|---|---|---|
Net income 2024 * | -89M -12.29M | Net income 2025 * | 98M 13.53M | EV / Sales 2024 * | 3.72 x |
Net Debt 2024 * | 133M 18.42M | Net cash position 2025 * | 64.26M 8.87M | EV / Sales 2025 * | 2.82 x |
P/E ratio 2024 * |
-37.4
x | P/E ratio 2025 * |
34.3
x | Employees | 1,066 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 16.99% |
1 day | +1.95% | ||
1 week | -7.01% | ||
1 month | +2.07% | ||
3 months | -0.34% | ||
6 months | -26.04% | ||
Current year | -25.79% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Lei Shen
CEO | Chief Executive Officer | - | 09-11-12 |
Liu Bin
DFI | Director of Finance/CFO | - | 20-01-04 |
Sabrina Wang
COO | Chief Operating Officer | - | 19-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Feng Mao Hua
BRD | Director/Board Member | 56 | 21-06-30 |
Yi Liang Wei
BRD | Director/Board Member | 53 | - |
Xiao Yan Liang
BRD | Director/Board Member | 58 | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.89 | +1.95% | 133,500 |
24-05-30 | 8.72 | -1.69% | 100,500 |
24-05-29 | 8.87 | -4.21% | 87,500 |
24-05-28 | 9.26 | -3.44% | 115,000 |
24-05-27 | 9.59 | +0.31% | 98,000 |
End-of-day quote Hong Kong S.E., May 30, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.79% | 454M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- 2315 Stock